Abstract: PO0134
Humoral Responses to Single-Dose BNT162b2 mRNA Vaccination in Dialysis Patients Previously Infected with SARS-CoV-2
Session Information
- COVID-19: Vaccines, Diagnosis, and Treatment
November 04, 2021 | Location: On-Demand, Virtual Only
Abstract Time: 10:00 AM - 12:00 PM
Category: Coronavirus (COVID-19)
- 000 Coronavirus (COVID-19)
Authors
- Speer, Claudius, University of Heidelberg, Heidelberg, Germany
- Nusshag, Christian, University of Heidelberg, Heidelberg, Germany
- Kälble, Florian, University of Heidelberg, Heidelberg, Germany
- Klein, Katrin, University of Heidelberg, Heidelberg, Germany
- Süsal, Caner, University of Heidelberg, Heidelberg, Germany
- Schnitzler, Paul, University of Heidelberg, Heidelberg, Germany
- Zeier, Martin G., University of Heidelberg, Heidelberg, Germany
- Morath, Christian, University of Heidelberg, Heidelberg, Germany
- Benning, Louise, University of Heidelberg, Heidelberg, Germany
Background
Seroconversion rates following infection and vaccination are lower in dialysis patients compared to healthy controls. There is an urgent need for the characterization of humoral responses and success of a single-dose SARS-CoV-2 vaccination in previously infected dialysis patients.
Methods
We performed a dual-center study with 43 dialysis patients after BNT162b2 vaccination and 25 dialysis patients after PCR-confirmed COVID-19. Single-dose vaccination was performed in 13 previously infected patients. Anti-S1 IgG, neutralizing antibodies, and antibodies against various SARS-CoV-2 epitopes were measured 6 weeks after the first vaccination or onset of COVID-19 and 3 weeks after single-dose vaccination.
Results
Previously infected patients without vaccination showed a significantly higher neutralizing capacity than patients vaccinated twice (median (IQR) percent inhibition 88.0 (71.5–95.5) vs. 50.7 (26.4–81.0); P=0.018). After one single vaccine dose, infected individuals generated 15- to 34-fold higher levels of anti-S1 IgG than age- and dialysis vintage-matched patients after infection or two-time vaccination with a median (IQR) index of 274 (151–791) compared to 18 (8–41) and 8 (1–21) (for both P<0.001). With a median (IQR) percent inhibition of 97.6 (97.2-98.9), the neutralizing capacity of SARS-CoV-2 antibodies was significantly higher in previously infected patients compared to other groups (for both P<0.01). Bead-based analysis showed high antibody reactivity against various SARS-CoV-2 spike protein epitopes after single-dose vaccination in previously infected patients.
Conclusion
Single-dose vaccination in previously infected dialysis patients induced a strong and broad antibody reactivity against various SARS-CoV-2 spike protein epitopes with high neutralizing capacity.